Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)

Hideaki Tani; Shotaro Takasu; Hiroyuki Uchida; Takefumi Suzuki; Masaru Mimura; Hiroyoshi Takeuchi

doi:10.1038/s41386-019-0598-y

Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)

Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, Takefumi Suzuki, Masaru Mimura, Hiroyoshi Takeuchi

Department of Psychiatry

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original version of this Article, the DOI doi.org/10.1016/j. schres.2019.09.013 was incorrectly listed for reference 9. It should instead be listed for reference 10. This has been corrected in both the PDF and HTML versions of the Article.

Original language	English
Pages (from-to)	902
Number of pages	1
Journal	Neuropsychopharmacology
Volume	45
Issue number	5
DOIs	https://doi.org/10.1038/s41386-019-0598-y
Publication status	Published - 2020 Apr 1

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41386-019-0598-y

Fingerprint

Dive into the research topics of 'Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)'. Together they form a unique fingerprint.

Cite this

Tani, H., Takasu, S., Uchida, H., Suzuki, T., Mimura, M., & Takeuchi, H. (2020). Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7). Neuropsychopharmacology, 45(5), 902. https://doi.org/10.1038/s41386-019-0598-y

Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7). / Tani, Hideaki; Takasu, Shotaro; Uchida, Hiroyuki et al.
In: Neuropsychopharmacology, Vol. 45, No. 5, 01.04.2020, p. 902.

Research output: Contribution to journal › Comment/debate › peer-review

Tani, H, Takasu, S, Uchida, H, Suzuki, T, Mimura, M & Takeuchi, H 2020, 'Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)', Neuropsychopharmacology, vol. 45, no. 5, pp. 902. https://doi.org/10.1038/s41386-019-0598-y

Tani H, Takasu S, Uchida H, Suzuki T, Mimura M, Takeuchi H. Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7). Neuropsychopharmacology. 2020 Apr 1;45(5):902. doi: 10.1038/s41386-019-0598-y

Tani, Hideaki ; Takasu, Shotaro ; Uchida, Hiroyuki et al. / Correction : Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7). In: Neuropsychopharmacology. 2020 ; Vol. 45, No. 5. pp. 902.

@article{daaa5e3e3cc44c0e9cfba8a3e38aefd4,

title = "Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)",

abstract = "In the original version of this Article, the DOI doi.org/10.1016/j. schres.2019.09.013 was incorrectly listed for reference 9. It should instead be listed for reference 10. This has been corrected in both the PDF and HTML versions of the Article.",

author = "Hideaki Tani and Shotaro Takasu and Hiroyuki Uchida and Takefumi Suzuki and Masaru Mimura and Hiroyoshi Takeuchi",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to American College of Neuropsychopharmacology.",

year = "2020",

month = apr,

day = "1",

doi = "10.1038/s41386-019-0598-y",

language = "English",

volume = "45",

pages = "902",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Correction

T2 - Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)

AU - Tani, Hideaki

AU - Takasu, Shotaro

AU - Uchida, Hiroyuki

AU - Suzuki, Takefumi

AU - Mimura, Masaru

AU - Takeuchi, Hiroyoshi

PY - 2020/4/1

Y1 - 2020/4/1

N2 - In the original version of this Article, the DOI doi.org/10.1016/j. schres.2019.09.013 was incorrectly listed for reference 9. It should instead be listed for reference 10. This has been corrected in both the PDF and HTML versions of the Article.

AB - In the original version of this Article, the DOI doi.org/10.1016/j. schres.2019.09.013 was incorrectly listed for reference 9. It should instead be listed for reference 10. This has been corrected in both the PDF and HTML versions of the Article.

UR - http://www.scopus.com/inward/record.url?scp=85078346124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078346124&partnerID=8YFLogxK

U2 - 10.1038/s41386-019-0598-y

DO - 10.1038/s41386-019-0598-y

M3 - Comment/debate

C2 - 31974442

AN - SCOPUS:85078346124

SN - 0893-133X

VL - 45

SP - 902

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 5

ER -

Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this